Sign In
Buy NOTV
$0.120
-0.140 (-53.96%)
At Close: Jun 03, 2026
Inotiv, Inc. (NOTV) Q3 2025 Earnings Call Transcript
03:09am, Thursday, 07'th Aug 2025
Inotiv, Inc. (NASDAQ:NOTV ) Q3 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Beth A. Taylor - Senior VP of Finance & CFO John E.
CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
09:16pm, Wednesday, 06'th Aug 2025
In a release issued under the same headline on August 6, 2025 by Inotiv, Inc. (NASDAQ: NOTV), please note that the amount of the recent draw request on the revolving credit facility has been corre
Inotiv, Inc. (NOTV) Reports Q3 Loss, Tops Revenue Estimates
06:51pm, Wednesday, 06'th Aug 2025
Inotiv, Inc. (NOTV) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.2 per share a year ago.
Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update
04:05pm, Wednesday, 06'th Aug 2025
– Third quarter fiscal 2025 revenue up 23.5% to $130.7 million– Year-to-date fiscal 2025 revenue increased 4.0% to $374.9 million– Conference call scheduled for today at 4:30 pm ET WEST LAFAYETT
Inotiv, Inc. to Report Fiscal 2025 Third Quarter Financial Results and Host Conference Call on Wednesday, August 6, 2025
07:00am, Wednesday, 23'rd Jul 2025
WEST LAFAYETTE, Ind., July 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analy
Inotiv, Inc. to Present at Jefferies Global Healthcare Conference 2025
04:05pm, Thursday, 22'nd May 2025
WEST LAFAYETTE, Ind., May 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analyti
Inotiv, Inc. (NOTV) Q2 2025 Earnings Call Transcript
12:03am, Thursday, 08'th May 2025
Call Start: 16:30 January 1, 0000 5:20 PM ET Inotiv, Inc. (NASDAQ:NOTV ) Q2 2025 Earnings Conference Call May 7, 2025, 04:30 PM ET Company Participants Steve Halper - Investor Relations Bob Leasure -
Inotiv, Inc. (NOTV) Reports Q2 Loss, Tops Revenue Estimates
07:45pm, Wednesday, 07'th May 2025
Inotiv, Inc. (NOTV) came out with a quarterly loss of $0.18 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.29 per share a year ago.
Inotiv Reports Second Quarter Financial Results for Fiscal 2025 and Provides Business Update
04:05pm, Wednesday, 07'th May 2025
— Second quarter fiscal 2025 revenue increased 4.4% to $124.3 million— Year-to-date fiscal 2025 revenue declined 4.1% to $244.2 million— Conference call scheduled for today at 4:30 pm ET W
Inotiv, Inc. (NOTV) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
11:06am, Wednesday, 30'th Apr 2025
Inotiv (NOTV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inotiv, Inc. to Report Fiscal 2025 Second Quarter Financial Results and Host Conference Call on Wednesday, May 7, 2025
04:05pm, Wednesday, 23'rd Apr 2025
WEST LAFAYETTE, Ind., April 23, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and anal
Inotiv, Inc. (NOTV) Q1 2025 Earnings Call Transcript
07:48pm, Wednesday, 05'th Feb 2025
Inotiv, Inc. (NASDAQ:NOTV ) Q1 2025 Results Conference Call February 5, 2025 4:30 PM ET Company Participants Steve Halper - Investor Relations Bob Leasure - President and Chief Executive Officer Beth
Inotiv, Inc. to Report Fiscal 2025 First Quarter Financial Results and Host Conference Call on Wednesday, February 5, 2025
04:05pm, Wednesday, 22'nd Jan 2025
WEST LAFAYETTE, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analy
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $3.6 Million
04:05pm, Monday, 30'th Dec 2024
WEST LAFAYETTE, Ind., Dec. 30, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discov
Inotiv, Inc. Completes Equity Offering for Net Proceeds of Approximately $24.0 Million
04:05pm, Monday, 23'rd Dec 2024
WEST LAFAYETTE, Ind., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”), a leading contract research organization specializing in nonclinical and analytical drug discov
